First, both Oncomine and TCGA whole patient cohorts show downregulation of LBH mRNA in invasive breast cancers (BRCA) compared to normal breast tissue, seemingly in contradiction with its reported oncogenic roles in breast carcinogenesis [13, 14, 46]. This evidence concerns the gene LBH and invasive breast carcinoma.